LifeSplice Pharma (United States)
- Research works
- 0 fractional, all time
- Citations
- 2 6.1 per fractional work
- Top-10% rate
- 0.0% all institutions 10.0%
- Open access
- 100% world 40%
Not ranked overall: LifeSplice Pharma (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does LifeSplice Pharma (United States) work in?
In all years, 100% of research at LifeSplice Pharma (United States) is in Life Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (67%), Neuroscience (33%).
Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 1 domains and 2 fields, with their numbers
- Life Sciences0100.0%
Which research topics does LifeSplice Pharma (United States) publish most on?
By volume: Neuroscience and Neuropharmacology Research, RNA regulation and disease and RNA and protein synthesis mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
Other research institutions in Malvern
- Siemens Healthcare (United States)
- Endo Pharmaceuticals (United States)
- Immaculata University
- Ricoh (United States)
- Reaction Biology Corporation (United States)
- Applied Pulsed Power (United States)
- TetraLogic Pharmaceuticals (United States)
- Saint-Gobain (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about LifeSplice Pharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.